MergerLinks Header Logo

Submit Deal

Submit Deal

Announced

Completed

Evolan Pharma completed the acquisition of Hydrokortison Trimb from Karo Pharma.

Synopsis

Evolan Pharma, a pharmaceutical company in Sweden, completed the acquisition of Hydrokortison Trimb, an OTC pharmaceutical product provider, from Karo Pharma, a pharmaceutical company. Financial terms were not disclosed. During the financial year 2018, the total sales of Hydrokortison Trimb amounted to SEK 19.8m.

Principals

Trimb Holding

target

Trimb Holding

Evolan Pharma

bidder

Evolan Pharma

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Dealmakers (3)

Service Providers

Sort

Richard Karroum

Richard Karroum

ManagerCEO at EVOLAN PHARMA
Deal Bio
Total Deals
1/
Total Value
value n/a
Christoffer Lorenzen

Christoffer Lorenzen

ManagerCEO at KARO PHARMA AB
Deal Bio
Total Deals
5/
Total Value
£953M
Carl Lindgren

Carl Lindgren

ManagerVP Business Development at KARO PHARMA AB
Deal Bio
Total Deals
3/
Total Value
£443M

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US